TransPRK in China — the cost, and why you were rerouted
Standard partner-hospital rates · Researched July 2026 · Published August 2026
$1,000–1,500 for both eyes, researched July 2026 — the least expensive line on our price table, for the one laser procedure that never touches your cornea with anything but light. TransPRK is also the procedure people arrive at sideways: they asked about LASIK, the workup said no, and the surgeon said "surface ablation" without ever explaining what on the printout made the call. This page covers both halves — the honest price anatomy of the cheapest procedure, and the rerouting conversation your consult was too short for.
What TransPRK actually is
Transepithelial photorefractive keratectomy is single-step surface ablation: one excimer laser removes the corneal epithelium and performs the correction in the same continuous pass. No flap is cut, no suction ring grips the eye, no blade or alcohol touches the surface, no second machine is involved — which is why the marketing name is "no-touch" or "all-laser" (全激光). Our partner centers run it on the SCHWIND AMARIS platform shown on the homepage table, the system on which single-step TransPRK was established. The epithelium you lose is not structural — it regrows in days — and that is the whole strategic point: the only permanent tissue change is the correction itself, with none of the ~100–110 µm flap overhead that LASIK's tissue math has to budget for.
The price, itemized — and why it's the cheapest line on the table
| Market | TransPRK, both eyes | Basis |
|---|---|---|
| China (partner standard rate) | $1,000–1,500 | Researched July 2026 — includes surgery, bandage lenses, routine in-China follow-up checks |
| United States | $3,500–5,000 | Published clinic ranges for surface ablation / PRK-class procedures |
| Western Europe | €2,500–3,500 | Published clinic ranges |
Both-eyes totals. Some markets advertise per-eye prices — halve nothing, double-check everything; the per-eye framing trap is covered on our LASIK cost page.
Why is the gap on this procedure the widest on our table (~70%)? Follow what the money buys. SMILE carries a per-procedure platform licence on the ZEISS system — a fee that is the same in Shanghai as in Chicago. EVO ICL carries a custom-manufactured STAAR lens whose price sets a hard floor under every quote on Earth. LASIK needs a femtosecond laser pass before the excimer even starts. TransPRK has none of these. It is one excimer laser working alone: no implant, no per-case fee, no second platform. When a procedure's cost is almost entirely surgeon time and theatre time, high-volume centers can compress it furthest — and China's refractive theatres run at volumes Western clinics don't see. The consumable-heavy procedures converge across countries; the theatre-time procedures diverge. TransPRK is the purest theatre-time procedure in refractive surgery, so it diverges most.
Trip math: the surgical rate excludes flights, hotel, and coordination. One planning note matters for this procedure specifically: the minimum stay is 3–5 days rather than LASIK's 3, because the bandage contact lens comes out only when the epithelium has closed — the clinical gate explained on the trip-length page. Budget one to two hotel nights more than a LASIK trip; even so, surgery plus a week on the ground typically totals less than the low end of a US surgical quote by itself.
The rerouting conversation your consult skipped
The most common TransPRK patient is someone who never asked for it. A workup comes back, the surgeon says "you're not suitable for LASIK, but surface ablation is fine," and the consultation moves on — leaving you to reverse-engineer the reasoning from a Reddit thread. Here is the reasoning. Each row is something a surgeon reads off your diagnostic printouts; any one of them can argue against a flap while leaving surface ablation open:
| What the workup found | Why it argues against a LASIK flap | Why surface ablation stays open |
|---|---|---|
| Pachymetry on the thin side | The flap spends ~100–110 µm of thickness before the correction starts; the residual stromal bed drops below the surgeon's safety margin | No flap means no overhead — the same correction leaves far more untouched stroma |
| Topography the surgeon wants to treat cautiously | A flap weakens the cornea's structure; on a map with any suspicious feature, surgeons avoid adding structural change | Surface ablation removes the least tissue and adds no interface — the conservative choice when a map is borderline rather than disqualifying |
| Epithelial fragility (basement-membrane dystrophy, past erosions) | Flap creation and a fragile epithelium are a poor combination | The procedure removes and regrows the epithelium anyway — fragility is managed, not aggravated |
| A marginal tear film | Cutting a flap severs more corneal nerves, which deepens and prolongs post-operative dry eye | Surface ablation disturbs fewer nerves; dryness still occurs but the structural contribution is smaller |
| Occupation or sport with eye-contact risk | A flap can, rarely, be displaced by trauma — for boxers, soldiers, some aircrew, that tail risk matters | After surface healing there is no flap to displace, ever — the reason some people choose TransPRK with normal corneas |
Orientation, not a diagnosis. Which factor applied to you — and whether the right answer was TransPRK, EVO ICL, or no surgery at all — is determined by the operating surgeon from your full workup. If you were rerouted without explanation, ask for the specific reading that made the call; it is on your printouts.
Where the prescription band itself is the issue — thin corneas and high myopia — the calculus shifts from TransPRK toward the ICL, because surface ablation still consumes tissue proportional to the correction. That boundary, band by band, is the options-map page's whole subject; the four-way procedure choice in general belongs to the comparator.
The recovery expectation, set honestly
TransPRK's price and its flap-free cornea are bought with time. The recovery timeline page owns the full day-by-day rhythm for all four procedures; what belongs here is the shape of the curve, because it is the thing clinics most often soft-pedal. The epithelium regrows under a bandage contact lens over roughly 3–5 days — the gritty, light-sensitive stretch, and the reason the "TransPRK recovers in 2 days like LASIK" claim you'll find online is a procedure confusion. Functional vision arrives in 1–2 weeks; sharpness then climbs for weeks more. Blur or fluctuation at day 10–14 sits inside the normal curve — the epithelium has closed but is still remodeling, and the refraction is still settling. Panic at day 11 is common in the forums and usually unwarranted; persistent worsening, pain, or a white spot is a different matter and goes to a clinician, promptly.
Two honest footnotes complete the picture. Haze: surface ablation can produce subepithelial haze during healing; with modern smooth ablation profiles it is uncommon and usually faint and transient, and for higher corrections surgeons commonly apply mitomycin-C intra-operatively as prophylaxis — a routine, evidence-backed step, not an alarm. Ultraviolet light: a healing surface is UV-sensitive for months, so sunglasses outdoors are a real instruction, not boilerplate — worth knowing before you book a beach holiday to celebrate your new eyes.
Questions people actually ask
How much does TransPRK cost in China?
$1,000–1,500 for both eyes at standard partner-hospital rates, researched July 2026 — the least expensive procedure on our price table, against typical published rates of $3,500–5,000 in the US and €2,500–3,500 in Western Europe. The number is the hospital's standard rate, not a teaser: it includes the surgery, the bandage contact lenses, and the routine in-China follow-up checks. Flights, hotel, and coordination sit outside it, and a written quote is confirmed after your diagnostic workup, before you book travel.
Why did my surgeon recommend TransPRK instead of LASIK?
Usually because something on your scans argued against cutting a flap: a pachymetry reading that leaves too little stromal bed after LASIK's ~100–110 µm flap overhead, a topography pattern the surgeon wants to treat without weakening the cornea further, signs of epithelial basement membrane fragility, a marginal tear film, or an occupation where a flap could be dislodged. Surface ablation removes no structural tissue beyond the correction itself, so it stays available when the flap math fails. Which of these applied to you is a question your operating surgeon can answer from your printouts — ask for the specific number or map that made the call; it exists.
How long does TransPRK recovery take?
Honestly: longer than LASIK, and longer than most clinics let on. The epithelium regrows under a bandage contact lens over roughly 3–5 days — the sandy, light-sensitive stretch. Functional vision for screens and travel typically arrives in 1–2 weeks, but acuity keeps climbing for weeks after that, and blur or fluctuation at day 10–14 is within the normal curve, not a sign of failure. Best corrected sharpness commonly lands over 1–3 months. The full day-by-day rhythm, milestone by milestone against the other three procedures, is on our recovery timeline page.
Is TransPRK as good as LASIK in the end?
For appropriately selected candidates, published studies report comparable endpoint visual outcomes between modern surface ablation and LASIK — the difference is the journey, not the destination: TransPRK trades weeks of slower recovery for a cornea that never has a flap in it. That trade is why aviation and contact-sport candidates sometimes choose it even when LASIK is available to them. Whether it is the right procedure for your eyes is determined by the operating surgeon from your diagnostic workup, not by the comparison in the abstract.
Why is TransPRK the cheapest procedure on the price table?
Because almost nothing about it is a consumable. SMILE carries a per-procedure platform licence, ICL carries a custom-manufactured lens that sets a hard floor, and LASIK adds a femtosecond flap pass. TransPRK is a single excimer laser working alone — one machine, one pass, no implant, no per-case fee. Procedures whose cost is mostly surgeon and theatre time are exactly where China's high-volume refractive centers price furthest below Western clinics, which is why the TransPRK gap (~70%) is the widest on our table. Prices researched July 2026.